세계의 생명과학 소프트웨어 시장(2024-2028년)

The life science software market is forecasted to grow by USD 4.56 bn during 2023-2028, accelerating at a CAGR of 8.58% during the forecast period. The report on the life science software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on storing patient information, increasing need for improving operational efficiency of life science data, and increasing technological innovations in life sciences software.

Technavio's life science software market is segmented as below:

By Deployment

• Cloud-based
• On-premises

By End-user

• Pharmaceutical
• Biotechnology
• Others

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the emergence of precision medicine as one of the prime reasons driving the life science software market growth during the next few years. Also, growing demand for SAAS-based life science software and rising adoption of analytics in life science software will lead to sizable demand in the market.

The report on the life science software market covers the following areas:

• Life science software market sizing
• Life science software market forecast
• Life science software market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading life science software market vendors that include ANSYS Inc., Bio Rad Laboratories Inc., Cegedim SA., Dassault Systemes SE, Dotmatics, eResearchTechnology GmbH, Fujitsu Ltd., Healthcare Radius, Hewlett Packard Enterprise Co., Honeywell International Inc., International Business Machines Corp., IQVIA Holdings Inc., Oracle Corp., PerkinElmer Inc, Salesforce Inc., SoftFormance, Thermo Fisher Scientific Inc., Trinity, Veeva Systems Inc., and ZS Associates Inc.. Also, the life science software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global life science software market 2018 - 2022
• 4.2 Deployment Segment Analysis 2018 - 2022
• 4.3 End-user Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Deployment

• 6.1 Market segments
• 6.2 Comparison by Deployment
• 6.3 Cloud-based - Market size and forecast 2023-2028
• 6.4 On-premises - Market size and forecast 2023-2028
• 6.5 Market opportunity by Deployment

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Pharmaceutical - Market size and forecast 2023-2028
• 7.4 Biotechnology - Market size and forecast 2023-2028
• 7.5 Others - Market size and forecast 2023-2028
• 7.6 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 APAC - Market size and forecast 2023-2028
• 9.6 South America - Market size and forecast 2023-2028
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
• 9.8 US - Market size and forecast 2023-2028
• 9.9 Germany - Market size and forecast 2023-2028
• 9.10 France - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 UK - Market size and forecast 2023-2028
• 9.13 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Bio Rad Laboratories Inc.
• 12.4 Cegedim SA.
• 12.5 Dassault Systemes SE
• 12.6 Dotmatics
• 12.7 Hewlett Packard Enterprise Co.
• 12.8 Honeywell International Inc.
• 12.9 International Business Machines Corp.
• 12.10 IQVIA Holdings Inc.
• 12.11 Oracle Corp.
• 12.12 PerkinElmer Inc
• 12.13 Salesforce Inc.
• 12.14 Thermo Fisher Scientific Inc.
• 12.15 Trinity
• 12.16 Veeva Systems Inc.
• 12.17 ZS Associates Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations